DOAJ Open Access 2020

Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin

Jordan Sexe Chadwick Mayes Peter Tofts

Abstrak

Diabetic ketoacidosis is a leading cause of morbidity and mortality in diabetic patients, and its diagnosis should be timely and accurate. SGLT2 inhibitors are a new class of antidiabetic medications that increase the renal excretion of glucose. It is thought that increased urinary excretion of glucose will mask hyperglycemia during DKA. This can lead to a delayed diagnosis of DKA and worsen outcomes. In this report, we detail a case of euglycemic DKA in a patient who presented to the Emergency Department meeting criteria for septic shock.

Topik & Kata Kunci

Medical emergencies. Critical care. Intensive care. First aid

Penulis (3)

Jordan Sexe

Chadwick Mayes

Peter Tofts

Format Sitasi

APA MLA BibTeX

Sexe, J., Mayes, C., Tofts, P. (2020). Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin. https://doi.org/10.1155/2020/7437892

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.1155/2020/7437892

Informasi Jurnal

Tahun Terbit: 2020
Sumber Database: DOAJ
DOI: 10.1155/2020/7437892
Akses: Open Access ✓